MedPath

Inflammatory Genetic Polymorphism and Acute Lung Injury After Cardiac Surgery

Completed
Conditions
Acute Lung Injury
Registration Number
NCT00826072
Lead Sponsor
Changhai Hospital
Brief Summary

Acute lung injury is a common complication of cardiac surgery with cardiopulmonary bypass, and it is significantly related to prolonged postoperative recovery, hospital stays and medical cost. Currently available predictors of acute lung injury after cardiac surgery are still limited within clinical data. Several genetic polymorphism of inflammatory mediators have been reported to be associated with severity of sepsis and ARDS, but the association of these inflammatory polymorphism and acute lung injury after cardiac surgery has never been reported. This study is performed to investigate the association of genetic polymorphisms including TNF -308A/G, IL-10 -1082A/G and IL-6 -572C/G and postoperative lung injury.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
107
Inclusion Criteria
  • Chinese Han unrelated population
  • adult patients
  • undergoing elective cardiac surgery with CPB
Exclusion Criteria
  • malignant tumor
  • autoimmune disease, immunodeficiency or immunosuppressive therapy
  • chronic renal disease (glomerular filtration rate < 60ml/(min•1.73m2)) or liver dysfunction (Child Pugh classification>A)
  • COPD, tuberculosis or other chronic pulmonary diseases
  • anemia with hemoglobin lower than 90mmHg
  • bleeding disorders
  • postoperative pericardial tamponade requiring re-operation
  • postoperative low cardiac output syndrome or acute pulmonary edema after left cardiac failure.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Acute lung injury after cardiac surgery with cardiopulmonary bypass24h after surgery
Secondary Outcome Measures
NameTimeMethod
circulating level of CRP, TNF-alpha, IL-10, IL-6; APACHE Ⅱ score; postoperative kidney injury, duration of ventilation, ICU stay and hospitalization; death in 28 days24h and 1 month after surgery

Trial Locations

Locations (1)

Changhai Hospital, Second Military Medical University

🇨🇳

Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath